Show simple item record

dc.contributor.authorDai, Chengkai
dc.contributor.authorSantagata, Sandro
dc.contributor.authorTang, Zijian
dc.contributor.authorShi, Jiayuan
dc.contributor.authorCao, Junxia
dc.contributor.authorKwon, Hyoungtae
dc.contributor.authorBronson, Roderick T.
dc.contributor.authorWhitesell, Luke
dc.contributor.authorLindquist, Susan
dc.date.accessioned2014-04-03T14:58:40Z
dc.date.available2014-04-03T14:58:40Z
dc.date.issued2012-09
dc.date.submitted2012-07
dc.identifier.issn0021-9738
dc.identifier.issn1558-8238
dc.identifier.urihttp://hdl.handle.net/1721.1/85987
dc.description.abstractIntrinsic stress response pathways are frequently mobilized within tumor cells. The mediators of these adaptive mechanisms and how they contribute to carcinogenesis remain poorly understood. A striking example is heat shock factor 1 (HSF1), master transcriptional regulator of the heat shock response. Surprisingly, we found that loss of the tumor suppressor gene neurofibromatosis type 1 (Nf1) increased HSF1 levels and triggered its activation in mouse embryonic fibroblasts. As a consequence, Nf1[superscript –/–] cells acquired tolerance to proteotoxic stress. This activation of HSF1 depended on dysregulated MAPK signaling. HSF1, in turn, supported MAPK signaling. In mice, Hsf1 deficiency impeded NF1-associated carcinogenesis by attenuating oncogenic RAS/MAPK signaling. In cell lines from human malignant peripheral nerve sheath tumors (MPNSTs) driven by NF1 loss, HSF1 was overexpressed and activated, which was required for tumor cell viability. In surgical resections of human MPNSTs, HSF1 was overexpressed, translocated to the nucleus, and phosphorylated. These findings reveal a surprising biological consequence of NF1 deficiency: activation of HSF1 and ensuing addiction to this master regulator of the heat shock response. The loss of NF1 function engages an evolutionarily conserved cellular survival mechanism that ultimately impairs survival of the whole organism by facilitating carcinogenesis.en_US
dc.description.sponsorshipUnited States. Army Medical Research and Materiel Command (Neurofibromatosis Research Program)en_US
dc.description.sponsorshipKathy and Curt Marble Cancer Research Funden_US
dc.language.isoen_US
dc.publisherAmerican Society for Clinical Investigationen_US
dc.relation.isversionofhttp://dx.doi.org/10.1172/jci62727en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourceLindquist via Courtney Crummetten_US
dc.titleLoss of tumor suppressor NF1 activates HSF1 to promote carcinogenesisen_US
dc.typeArticleen_US
dc.identifier.citationDai, Chengkai, Sandro Santagata, Zijian Tang, Jiayuan Shi, Junxia Cao, Hyoungtae Kwon, Roderick T. Bronson, Luke Whitesell, and Susan Lindquist. “Loss of Tumor Suppressor NF1 Activates HSF1 to Promote Carcinogenesis.” J. Clin. Invest. 122, no. 10 (October 1, 2012): 3742–3754.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentWhitehead Institute for Biomedical Researchen_US
dc.contributor.approverLindquist, Susanen_US
dc.contributor.mitauthorLindquist, Susanen_US
dc.relation.journalJournal of Clinical Investigationen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsDai, Chengkai; Santagata, Sandro; Tang, Zijian; Shi, Jiayuan; Cao, Junxia; Kwon, Hyoungtae; Bronson, Roderick T.; Whitesell, Luke; Lindquist, Susanen_US
dc.identifier.orcidhttps://orcid.org/0000-0003-1307-882X
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record